Monday, January 06, 2020 12:23:21 PM
TTNP - Titan Pharmaceuticals Inc Forecast - Business - CNN ...
https://money.cnn.com › quote › forecast › forecast › symb=TTNP
Titan Pharmaceuticals Inc (NASDAQ:TTNP) The 2 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00
=========================================================================
CNN Business News has DISMAL ratings VS CNBC-----The ratings are SOOOOO BAD----that they are desperate to stay alive, or close the doors. I can see them approaching Marc & Sunil---or vice versa for Xchange of $ for an excellent rating of some sorts. I'm a 3 year big loser here, but I'm happy to see any kind of "boost"---There may also be some insider leaks of good news to come (highly unlikely) IMO this is just some short-lived fireworks----good for new flippers---What's your take Melody?--Would like to hear your respected opinion.
Recent TTNP News
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 10/14/2025 08:05:15 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 10/09/2025 09:30:37 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:30:34 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 10/09/2025 09:21:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2025 12:21:28 AM
- Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities • Edgar (US Regulatory) • 10/02/2025 12:47:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/01/2025 08:20:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2025 08:05:34 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2025 04:28:17 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/14/2025 09:16:04 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 07/22/2025 09:06:53 PM
- Form DEFM14A - Definitive proxy statement relating to merger or acquisition • Edgar (US Regulatory) • 07/22/2025 09:04:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/27/2025 08:15:19 PM
- Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 06/27/2025 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2025 08:49:02 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 06/03/2025 09:25:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 09:25:13 PM
- Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd. • GlobeNewswire Inc. • 06/03/2025 12:45:44 PM
